Back to results
US 2019/0161502 A1Published application
1,4-oxazines useful as selective bace1 inhibitors
AssigneeEli Lilly and Company
InventorsSteven James Green, Erik James Hembre, II, Dustin James Mergott
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, useful as a BACE1 inhibitor.
Claims13
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
A compound which is N-[3-[(3R,6R)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-4-fluoro-phenyl]-5-cyano-thiazolo[5,4-b]pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.